tiprankstipranks
Trending News
More News >
Fulgent Genetics Inc (FLGT)
NASDAQ:FLGT
US Market

Fulgent Genetics (FLGT) Income Statement

Compare
1,641 Followers

Fulgent Genetics Income Statement

Last quarter (Q3 2025), Fulgent Genetics's total revenue was $84.07M, an increase of 17.18% from the same quarter last year. In Q3, Fulgent Genetics's net income was $-6.61M. See Fulgent Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 283.47M$ 289.21M$ 618.97M$ 992.58M$ 421.71M
Gross Profit
$ 107.22M$ 104.46M$ 366.90M$ 777.05M$ 331.90M
Operating Expenses
$ 181.13M$ 299.99M$ 188.37M$ 101.10M$ 41.75M
Depreciation and Amortization
$ 24.93M$ 26.14M$ 32.66M$ 11.00M$ 2.96M
EBITDA
$ -48.99M$ -147.45M$ 217.70M$ 686.96M$ 293.12M
Operating Income
$ -73.92M$ -195.53M$ 178.53M$ 675.95M$ 290.16M
Other Income/Expenses
$ 21.96M$ 21.44M$ 5.50M$ 5.08M$ -3.32M
Pretax Income
$ -51.96M$ -174.09M$ 184.03M$ 681.03M$ 286.84M
Net Income
$ -42.71M$ -167.82M$ 143.40M$ 507.36M$ 214.31M
Per Share Metrics
Basic EPS
$ -1.41$ -5.63$ 4.76$ 17.13$ 9.44
Diluted EPS
$ -1.41$ -5.63$ 4.63$ 16.26$ 8.91
Weighted Average Shares Outstanding
30.23M 29.78M 30.10M 29.41M 22.69M
Weighted Average Shares Outstanding (Diluted)
30.23M 29.78M 30.96M 30.98M 24.06M
Currency in USD

Fulgent Genetics Earnings and Revenue History